An AllTrials project

NCT02841709: A reported trial by Idorsia Pharmaceuticals Ltd.

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT02841709
Title Multi-center, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Polysomnography Dose-response Study to Assess the Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
Results Status Reported
ACT or pACT? This is what FDAAA officially calls a "probable Applicable Clinical Trial"
Start date Nov. 28, 2016
Completion date May 31, 2017
Required reporting date May 31, 2020, midnight
Actual reporting date March 6, 2020
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None